Morningstar

Virtus KAR Health Sciences A RAGHX

Morningstar Medalist Rating
Medalist Rating as of | See Virtus Investment Hub
  • NAV / 1-Day Return 30.00  /  +0.20 %
  • Total Assets 138.2 Mil
  • Adj. Expense Ratio
    1.390%
  • Expense Ratio 1.390%
  • Distribution Fee Level Above Average
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 6%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis RAGHX

Will RAGHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable RAGHX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the RAGHX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of RAGHX’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit Virtus KAR Health Sciences A to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RAGHX

More RAGHX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 51.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

13.29 19.4 Mil
Healthcare

UnitedHealth Group Inc

4.84 7.1 Mil
Healthcare

AbbVie Inc

4.82 7.0 Mil
Healthcare

Vertex Pharmaceuticals Inc

4.29 6.3 Mil
Healthcare

Merck & Co Inc

4.27 6.2 Mil
Healthcare

Edwards Lifesciences Corp

4.07 5.9 Mil
Healthcare

McKesson Corp

4.06 5.9 Mil
Healthcare

The Cooper Companies Inc

4.01 5.8 Mil
Healthcare

IDEXX Laboratories Inc

3.90 5.7 Mil
Healthcare

Danaher Corp

3.82 5.6 Mil
Healthcare

Sponsor Center